ATE440132T1 - Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger - Google Patents

Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger

Info

Publication number
ATE440132T1
ATE440132T1 AT03768918T AT03768918T ATE440132T1 AT E440132 T1 ATE440132 T1 AT E440132T1 AT 03768918 T AT03768918 T AT 03768918T AT 03768918 T AT03768918 T AT 03768918T AT E440132 T1 ATE440132 T1 AT E440132T1
Authority
AT
Austria
Prior art keywords
bacillus subtilis
use against
against animal
human diseases
factor
Prior art date
Application number
AT03768918T
Other languages
English (en)
Inventor
Huay Lin Angeline Seah
Alex Teo
Hai Tan
Original Assignee
Kemin Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Ind Inc filed Critical Kemin Ind Inc
Application granted granted Critical
Publication of ATE440132T1 publication Critical patent/ATE440132T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03768918T 2002-11-27 2003-11-12 Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger ATE440132T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/306,365 US7247299B2 (en) 2002-11-27 2002-11-27 Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
PCT/US2003/036094 WO2004050832A2 (en) 2002-11-27 2003-11-12 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens

Publications (1)

Publication Number Publication Date
ATE440132T1 true ATE440132T1 (de) 2009-09-15

Family

ID=32325671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03768918T ATE440132T1 (de) 2002-11-27 2003-11-12 Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger

Country Status (10)

Country Link
US (1) US7247299B2 (de)
EP (1) EP1576120B1 (de)
JP (1) JP4989851B2 (de)
AT (1) ATE440132T1 (de)
AU (1) AU2003291514B2 (de)
CA (1) CA2503130C (de)
DE (1) DE60328916D1 (de)
ES (1) ES2331993T3 (de)
NZ (1) NZ568391A (de)
WO (1) WO2004050832A2 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104175A2 (en) * 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
MXPA06013253A (es) * 2004-05-14 2007-02-28 Agtech Products Inc Metodo y composicion para reducir la enfermedad de e. coli disease y mejorar el rendimiento utilizando bacilos.
JP3988953B2 (ja) * 2005-11-04 2007-10-10 株式会社エー・エイチ・シー 抗菌活性物質ｄｍ０５０７およびその利用
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
US8021654B2 (en) * 2008-03-14 2011-09-20 Danisco A/S Methods of treating pigs with Bacillus strains
WO2009146205A1 (en) 2008-04-17 2009-12-03 Agtech Products, Inc. Bacillus strains useful for animal odor control
US8540981B1 (en) 2008-07-07 2013-09-24 Dupont Nutrition Biosciences Aps Bacillus strains useful against calf pathogens and scours
ES2567296T3 (es) * 2008-09-17 2016-04-21 Bayer Cropscience Lp Procedimiento para usar una cepa de Bacillus subtilis para potenciar la salud animal
JP5620392B2 (ja) * 2008-11-03 2014-11-05 タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物
WO2011099514A1 (ja) 2010-02-10 2011-08-18 日環科学株式会社 好熱性微生物を用いた混合物、溶解液、及び医薬品
DK2547348T3 (da) * 2010-03-17 2015-08-24 Bayer Cropscience Lp Fremgangsmåde til anvendelse af en bacillus subtilis-stamme til profylakse og behandling af mave-tarm-tilstande
BR112013001107B1 (pt) 2010-07-16 2022-01-25 The Board Of Trustees Of The University Of Arkansas Métodos e composições incluindo bactéria formadora de esporos para aumento da saúde dos animais
RU2553547C2 (ru) * 2010-09-15 2015-06-20 Инвестигасьон Де Текнология Аванзада, С.А. Де К.В. ШТАММ Bacillus subtilis, ВЫРАБАТЫВАЮЩИЙ ПЕПТИД С ПРОТИВОМИКРОБНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИНГИБИРОВАНИЯ НЕЖЕЛАТЕЛЬНЫХ МИКРООРГАНИЗМОВ В МАТЕРИАЛЕ С ИСПОЛЬЗОВАНИЕМ ШТАММА
WO2012044984A1 (en) 2010-09-30 2012-04-05 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
US9023345B2 (en) * 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
CA2834382C (en) 2011-04-29 2020-07-21 Auburn University Bacillus bacteria for use in treating and preventing infection in aquatic animals
US8557234B1 (en) 2011-05-18 2013-10-15 Dupont Nutrition Biosciences Aps Methods of controlling pit foam
PL2748300T3 (pl) 2011-08-24 2019-05-31 Dupont Nutrition Biosci Aps Szczepy Bacillus wytwarzające enzym
MX2014009103A (es) 2012-01-27 2015-11-18 Gfs Corp Aus Pty Ltd Métodos para producir biosurfactantes.
US9393275B2 (en) 2012-08-01 2016-07-19 Novozymes A/S Probiotic for amelioration of coccidiosis vaccine reaction
RU2534356C2 (ru) * 2012-10-04 2014-11-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Россельхозакадемии (ГНУ ИЭВСиДВ Россельхозакадемии) Способ контроля качества дезинфекции птицеводческих помещений
WO2014151837A1 (en) * 2013-03-15 2014-09-25 Bayer Cropscience Lp A bacillus subtilis strain for use in maintaining or improving the paw health of poultry
EP3203858A1 (de) * 2014-10-08 2017-08-16 Novozymes A/S Bazillusstämme mit schneller keimung und antimikrobieller aktivität gegen clostridium perfringens
WO2016118850A1 (en) 2015-01-23 2016-07-28 Novozymes A/S Bacillus subtilis subspecies
FI3247788T3 (fi) 2015-01-23 2023-08-18 Novozymes As Bacillus-kannat, jotka parantavat tuotantoeläinten terveyttä ja suorituskykyä
WO2016118840A1 (en) 2015-01-23 2016-07-28 Novozymes A/S Bacillus strains improving health and performance of production animals
US10201574B1 (en) 2015-09-16 2019-02-12 Church & Dwight Co., Inc. Methods of microbial treatment of poultry
US11298383B2 (en) 2016-05-20 2022-04-12 Church & Dwight Co., Inc. Lactobacillus and bacillus based direct fed microbial treatment for poultry and method of use
CN117004520A (zh) 2016-05-25 2023-11-07 丘奇和德怀特有限公司 芽孢杆菌属组合物及用于反刍动物的方法
EP3464557A1 (de) 2016-05-31 2019-04-10 Evonik Degussa GmbH Bacillus licheniformis
US11173184B2 (en) 2016-05-31 2021-11-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
EP3645750A1 (de) 2017-06-30 2020-05-06 Evonik Operations GmbH Bacillus pumilus
US20200113952A1 (en) 2017-06-30 2020-04-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
US11622569B2 (en) 2017-07-24 2023-04-11 Church & Dwight Co., Inc. Bacillus microbial terroir for pathogen control in swine
EP3447122A1 (de) 2017-08-24 2019-02-27 Evonik Degussa GmbH Bacillus-subtilis-stamm mit probiotischer aktivität
WO2019038153A1 (en) 2017-08-24 2019-02-28 Evonik Degussa Gmbh DEBACILLUS SUBTILIS STRAIN HAVING PROBIOTIC ACTIVITY
CN108865953B (zh) * 2018-07-25 2021-07-13 中国海洋大学 一株广谱抑制水产病原性弧菌的芽孢杆菌及其复合菌制剂
WO2020144207A1 (en) 2019-01-10 2020-07-16 Evonik Operations Gmbh Fermentation broths and their use
JP7689077B2 (ja) 2019-02-11 2025-06-05 エボニック オペレーションズ ゲーエムベーハー バシラエン産生細菌またはその調製物を含有する組成物
CN110894132A (zh) * 2019-12-17 2020-03-20 海天水务集团股份公司 一种基于fcr的污水处理方法
US20230059825A1 (en) 2020-01-14 2023-02-23 Evonik Operations Gmbh Bacillus strains with the ability to degrade inorganic nitrogen compounds
MX2022008789A (es) * 2020-01-17 2023-01-24 Agbiome Inc Composiciones y métodos para controlar los microbios indeseables y mejorar la salud animal.
WO2021183983A2 (en) * 2020-03-13 2021-09-16 Kemin Industries, Inc. A method for controlling clostridium infection in animals
MX2023006676A (es) 2020-12-09 2023-07-04 Purina Animal Nutrition Llc Composiciones alimenticias y metodos para inhibir dermatitis ulcerosa focal.
EP4130258A1 (de) 2021-08-02 2023-02-08 Evonik Operations GmbH Virale decoy-rezeptoren aufweisende mikroorganismen
EP4166002A1 (de) 2021-10-12 2023-04-19 Evonik Operations GmbH Mikrobielle zubereitungen mit spezifischen kryoprotektoren
EP4230721A1 (de) 2022-02-17 2023-08-23 Evonik Operations GmbH Mikroorganismen mit reduzierter kompetenz
EP4230722A1 (de) 2022-02-17 2023-08-23 Evonik Operations GmbH Bacillota-stämme mit verbesserter ausbreitung
WO2023180282A1 (en) 2022-03-24 2023-09-28 Evonik Operations Gmbh Co-precipitates of methionylmethionine with organic compounds
WO2023220279A1 (en) * 2022-05-12 2023-11-16 Can Technologies, Inc. Compositions and methods for the treatment and prevention of campylobacter infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545991A (en) * 1983-06-13 1985-10-08 Merck & Co., Inc. Difficidin and derivative antibacterials
DE3778225D1 (de) * 1986-06-30 1992-05-21 American Cyanamid Co Antibiotikum ll-e19020 alpha und beta.
US4968493A (en) * 1986-06-30 1990-11-06 American Cyanamid Company Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species
US5352586A (en) * 1987-05-01 1994-10-04 Biogaia Ab Method of determining the presence of an antibiotic produced by Lactobacillus reuteri
JPH0818996B2 (ja) * 1987-10-31 1996-02-28 カルピス食品工業株式会社 抗クロストリジウム生菌剤
DK0463393T3 (da) * 1990-06-22 1995-12-18 Eniricerche Spa Mutant af bacillus subtilis og fremgangsmåde til fremstilling af surfactin ved hjælp af mutanten
DE69225454T2 (de) * 1991-07-01 1998-10-01 Ahc Inc Bacillus Bakterium und dessen Verwendung
DE69223302T2 (de) * 1991-09-09 1998-04-09 Hoffmann La Roche Antibiotikum LL-E19020 Gamma
ZA926834B (en) * 1991-09-09 1993-03-15 American Cyanamid Co Antibiotic LL-E19020 Gamma.
JP2528055B2 (ja) * 1991-10-04 1996-08-28 カルピス食品工業株式会社 鳥類飼料添加用腸内サルモネラ属細菌減少剤及びその使用法
WO1999028441A1 (en) 1997-12-01 1999-06-10 Eisai Co., Ltd. Novel bacillus subtilis with antibacterial effects
UA78486C2 (uk) * 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)

Also Published As

Publication number Publication date
JP2006514019A (ja) 2006-04-27
WO2004050832A2 (en) 2004-06-17
EP1576120A4 (de) 2006-06-07
EP1576120B1 (de) 2009-08-19
US20040101525A1 (en) 2004-05-27
WO2004050832A3 (en) 2005-09-15
AU2003291514A1 (en) 2004-06-23
ES2331993T3 (es) 2010-01-22
AU2003291514B2 (en) 2008-10-09
DE60328916D1 (de) 2009-10-01
CA2503130C (en) 2012-03-13
EP1576120A2 (de) 2005-09-21
CA2503130A1 (en) 2004-06-17
US7247299B2 (en) 2007-07-24
NZ568391A (en) 2009-04-30
JP4989851B2 (ja) 2012-08-01

Similar Documents

Publication Publication Date Title
ATE440132T1 (de) Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger
DE60129823D1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
Liu et al. Frequency of biocide-resistant genes and susceptibility to chlorhexidine in high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MuH MRSA)
Bin-Asif et al. The genus Enterococcus and its associated virulent factors
WO2009088549A3 (en) Methods of inhibiting bacterial virulence and compounds relating thereto
MX336242B (es) Uso de los compuestos a base de lantibioticos del tipo b que tienen actividad antimicrobiana.
DE60316772D1 (de) Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen
WO2008041966A3 (en) Broad spectrum antibacterial compounds
WO2004103208A3 (en) Manufacture and use of implantable reticulated elastomeric matrices
MX2009007345A (es) Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo.
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
Arciola et al. Presence of fibrinogen-binding adhesin gene in Staphylococcus epidermidis isolates from central venous catheters-associated and orthopaedic implant-associated infections
CY1110896T1 (el) Μια νεα αντιμυκητιακη συνθεση
WO2009022185A3 (en) 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use
DE50306587D1 (de) Antibakterielle amid-makrozyklen
TW200738249A (en) Harmful bacterium control agent containing bacillus thuringiensis
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
Sood et al. Multidrug resistant Bacillus cereus in fresh vegetables: A serious burden to public health
ATE383163T1 (de) Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen
WO2007092582A3 (en) Neutralization of bacterial spores
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
Yan et al. Complete genome sequence of Bacillus amyloliquefaciens B15 isolated from grape skin, a strain of strong inhibitory activity against fungi
UA85187C2 (en) 2-aminobenzoyl derivatives
Handayani et al. Staphylococcal enterotoxin a gene–carrying Staphylococcus aureus isolated from foods and its control by crude alkaloid from papaya leaves
RU2003110469A (ru) Штамм бактерий bacillus subtilis ч-13

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties